Nurr1 regulates dopamine synthesis and storage in MN9D dopamine cells

Experimental Cell Research

Volumn 288, Issue 2, 2003, Pages 324-334

  Hermanson, Elisabet ^a   Joseph, Bertrand ^a,b   Castro, Diogo ^a,d   Lindqvist, Eva ^b   Aarnisalo, Piia ^a,e   Wallén, Åsa ^a,f   Benoit, Gerard ^a   Hengerer, Bastian ^c   Olson, Lars ^b   Perlmann, Thomas ^a,b  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c NOVARTIS PHARMA AG   (Switzerland)

^d INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^e UNIVERSITY OF HELSINKI   (Finland)

^f ASTRAZENECA R AND D   (Sweden)

Author keywords

Catecholamine synthesis; Dopamine neuron; Orphan nuclear receptor; Retinoic acid; Steroid hormone receptor; Transcription factor

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE; DOPAMINE; NUCLEAR RECEPTOR RELATED FACTOR 1; PROTEIN; RETINOIC ACID; RETINOID; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER 2;

ANIMAL TISSUE; ARTICLE; CELL LEVEL; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; EMBRYO; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM;

EID: 0043065330     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00216-7     Document Type: Article

References (39)

1. Elsworth J.D., Roth R.H. Dopamine synthesis, uptake, metabolism, and receptors relevance to gene therapy of Parkinson's disease . Exp. Neurol. 144:1997;4-9.
2. Shastry B.S. Parkinson disease etiology, pathogenesis and future of gene therapy . Neurosci. Res. 41:2001;5-12.
3. Law S.W., Conneely O.M., DeMayo F.J., O'Malley B.W. Identification of a new brain-specific transcription factor, NURR1. Mol. Endocrinol. 6:1992;2129-2135.
4. Aranda A., Pascual A. Nuclear hormone receptors and gene expression. Physiol. Rev. 81:2001;1269-1304.
5. Wilson T.E., Paulsen R.E., Padgett K.A., Milbrandt J. Participation of non-zinc finger residues in DNA binding by two nuclear orphan receptors. Science. 256:1992;107-110.
6. Wilson T.E., Fahrner T.J., Milbrandt J. The orphan receptors NGFI-B and steroidogenic factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction. Mol. Cell. Biol. 13:1993;5794-5804.
7. Perlmann T., Jansson L. A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev. 9:1995;769-782.
8. Forman B.M., Umesono K., Chen J., Evans R.M. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell. 81:1995;541-550.
9. Philips A., Lesage S., Gingras R., Maira M.H., Gauthier Y., Hugo P., Drouin J. Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells. Mol. Cell. Biol. 17:1997;5946-5951.
10. Maira M., Martens C., Philips A., Drouin J. Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation. Mol. Cell. Biol. 19:1999;7549-7557.
11. Zetterstrom R.H., Solomin L., Mitsiadis T., Olson L., Perlmann T. Retinoid X receptor heterodimerization and developmental expression distinguish the orphan nuclear receptors NGFI-B, Nurr1, and Nor1. Mol. Endocrinol. 10:1996;1656-1666.
12. Zetterstrom R.H., Williams R., Perlmann T., Olson L. Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system. Brain Res. Mol. Brain Res. 41:1996;111-120.
13. Zetterstrom R.H., Solomin L., Jansson L., Hoffer B.J., Olson L., Perlmann T. Dopamine neuron agenesis in Nurr1-deficient mice. Science. 276:1997;248-250.
14. Castillo S.O., Baffi J.S., Palkovits M., Goldstein D.S., Kopin I.J., Witta J., Magnuson M.A., Nikodem V.M. Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene. Mol. Cell. Neurosci. 11:1998;36-46.
15. Saucedo-Cardenas O., Quintana-Hau J.D., Le W.D., Smidt M.P., Cox J.J., De Mayo F., Burbach J.P., Conneely O.M. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc. Natl. Acad. Sci. USA. 95:1998;4013-4018.
16. Wallen A.A., Castro D.S., Zetterstrom R.H., Karlen M., Olson L., Ericson J., Perlmann T. Orphan nuclear receptor nurr1 is essential for ret expression in midbrain dopamine neurons and in the brain stem. Mol. Cell. Neurosci. 18:2001;649-663.
17. Wallen A., Zetterstrom R.H., Solomin L., Arvidsson M., Olson L., Perlmann T. Fate of mesencephalic AHD2-expressing dopamine progenitor cells in NURR1 mutant mice. Exp. Cell Res. 253:1999;737-746.
18. Choi H.K., Won L.A., Kontur P.J., Hammond D.N., Fox A.P., Wainer B.H., Hoffmann P.C., Heller A. Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion. Brain Res. 552:1991;67-76.
19. Choi W.S., Canzoniero L.M., Sensi S.L., O'Malley K.L., Gwag B.J., Sohn S., Kim J.E., Oh T.H., Lee E.B., Oh Y.J. Characterization of MPP(+)-induced cell death in a dopaminergic neuronal cell line role of macromolecule synthesis, cytosolic calcium, caspase, and Bcl-2-related proteins . Exp. Neurol. 159:1999;274-282.
20. Kim H.E., Yoon S.Y., Lee J.E., Choi W.S., Jin B.K., Oh T.H., Markelonis G.J., Chun S.Y., Oh Y.J. MPP(+) downregulates mitochondrially encoded gene transcripts and their activities in dopaminergic neuronal cells protective role of Bcl-2 . Biochem. Biophys. Res. Commun. 286:2001;659-665.
21. Choi W.S., Chun S.Y., Markelonis G.J., Oh T.H., Oh Y.J. Overexpression of calbindin-D28K induces neurite outgrowth in dopaminergic neuronal cells via activation of p38 MAPK. Biochem. Biophys. Res. Commun. 287:2001;656-661.
22. Heller A., Price S., Won L. Glial-derived neurotrophic factor (GDNF) induced morphological differentiation of an immortalized monoclonal hybrid dopaminergic cell line of mesencephalic neuronal origin. Brain Res. 725:1996;132-136.
23. Swarzenski B.C., O'Malley K.L., Todd R.D. PTX-sensitive regulation of neurite outgrowth by the dopamine D3 receptor. NeuroReport. 7:1996;573-576.
24. Oh Y.J., Swarzenski B.C., O'Malley K.L. Overexpression of Bcl-2 in a murine dopaminergic neuronal cell line leads to neurite outgrowth. Neurosci. Lett. 202:1996;161-164.
25. Castro D.S., Hermanson E., Joseph B., Wallen A., Aarnisalo P., Heller A., Perlmann T. Induction of cell cycle arrest and morphological differentiation by Nurr1 and retinoids in dopamine MN9D cells. J. Biol. Chem. 276:2001;43277-43284.
26. Sakurada K., Ohshima-Sakurada M., Palmer T.D., Gage F.H. Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. Development. 126:1999;4017-4026.
27. Zhou Q.Y., Quaife C.J., Palmiter R.D. Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature. 374:1995;640-643.
28. Ohkura N., Hosono T., Maruyama K., Tsukada T., Yamaguchi K. An isoform of Nurr1 functions as a negative inhibitor of the NGFI-B family signaling. Biochim. Biophys. Acta. 1444:1999;69-79.
29. Kaneda N., Sasaoka T., Kobayashi K., Kiuchi K., Nagatsu I., Kurosawa Y., Fujita K., Yokoyama M., Nomura T., Katsuki M., et al. Tissue-specific and high-level expression of the human tyrosine hydroxylase gene in transgenic mice. Neuron. 6:1991;583-594.
30. Andersson H., Luthman J., Lindqvist E., Olson L. Time-course of trimethyltin effects on the monoaminergic systems of the rat brain. Neurotoxicology. 16:1995;201-210.
31. Smidt M.P., Asbreuk C.H., Cox J.J., Chen H., Johnson R.L., Burbach J.P. A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b. Nature Neurosci. 3:2000;337-341.
32. Iwawaki T., Kohno K., Kobayashi K. Identification of a potential nurr1 response element that activates the tyrosine hydroxylase gene promoter in cultured cells. Biochem. Biophys. Res. Commun. 274:2000;590-595.
33. Sacchetti P., Brownschidle L.A., Granneman J.G., Bannon M.J. Characterization of the 5′-flanking region of the human dopamine transporter gene. Brain Res. Mol. Brain Res. 74:1999;167-174.
34. Bannon M.J., Pruetz B., Manning-Bog A.B., Whitty C.J., Michelhaugh S.K., Sacchetti P., Granneman J.G., Mash D.C., Schmidt C.J. Decreased expression of the transcription factor NURR1 in dopamine neurons of cocaine abusers. Proc. Natl. Acad. Sci. USA. 16:2002;16.
35. Lee W.Y., Chang J.W., Nemeth N.L., Kang U.J. Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase enhance dopamine delivery after L-3, 4-dihydroxyphenylalanine administration in parkinsonian rats. J. Neurosci. 19:1999;3266-3274.
36. Li X.M., Juorio A.V., Qi J., Boulton A.A. L-deprenyl induces aromatic L-amino acid decarboxylase (AADC) mRNA in the rat substantia nigra and ventral tegmentum. An in situ hybridization study. Mol. Chem. Neuropathol. 35:1998;149-155.
37. Y. Chu, E.J. Cochran, E.J. Mufson, J.H. Kordower, Reduction of Nurr1 expression in substantia nigra of patients with Parkinson's disease, Society for Neuroscience abstract, No 967.1, 2001.
38. Takahashi N., Miner L.L., Sora I., Ujike H., Revay R.S., Kostic V., Jackson-Lewis V., Przedborski S., Uhl G.R. VMAT2 knockout mice heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity . Proc. Natl. Acad. Sci. USA. 94:1997;9938-9943.
39. Weingarten P., Zhou Q.Y. Protection of intracellular dopamine cytotoxicity by dopamine disposition and metabolism factors. J. Neurochem. 77:2001;776-785.